QIAGEN

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

CEO

Jonathan M. Pratt

CEOJonathan M. Pratt

Employees

5,654

Employees5,654

Headquarters

Venlo, Limburg

HeadquartersVenlo, Limburg

Founded

1996

Founded1996

Employees

5,654

Employees5,654

QGEN Key Statistics

Market cap

10.38B

Market cap10.38B

Price-Earnings ratio

25.56

Price-Earnings ratio25.56

Dividend yield

0.70%

Dividend yield0.70%

Average volume

8.90M

Average volume8.90M

High today

$50.40

High today$50.40

Low today

$50.10

Low today$50.10

Open price

$50.17

Open price$50.17

Volume

2.72M

Volume2.72M

52 Week high

$57.82

52 Week high$57.82

52 Week low

$32.53

52 Week low$32.53

Stock Snapshot

QIAGEN(QGEN) stock is priced at $50.37, giving the company a market capitalization of 10.38B. It carries a P/E multiple of 25.56 and pays a dividend yield of 0.70%.

On 2026-10-29, QIAGEN(QGEN) stock traded between a low of $50.10 and a high of $50.40. Shares are currently priced at $50.37, which is +0.5% above the low and -0.1% below the high.

QIAGEN(QGEN) shares are trading with a volume of 2.72M, against a daily average of 8.9M.

During the past year, QIAGEN(QGEN) stock moved between $32.53 at its lowest and $57.82 at its peak.

QGEN News

Simply Wall St 4d

Qiagen Is Back In Focus, What Is Behind The Fresh Attention?

Qiagen (QGEN) is back in focus after agreeing to a €9.7b takeover by an EQT-led consortium. The company also suspended its 2026 earnings guidance and flagged a...

TipRanks 6d

QIAGEN Agrees to €46.50-Per-Share Takeover by Crown NL Bidco

Qiagen ( (QGEN) ) just unveiled an announcement. On October 21, 2026, QIAGEN N.V. and Crown NL Bidco B.V. signed a Business Combination Agreement for a planned...

TipRanks 6d

Qiagen downgraded to Hold from Buy at DZ Bank

DZ Bank analyst Sven Kuerten downgraded Qiagen (QGEN) to Hold from Buy after the company reached an agreement to be acquired by EQT AB for EUR 46.50 per share....

Analyst ratings

89%

of 18 ratings

Buy

11.1%

Hold

88.9%

Sell

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Pfizer

Moderna

Disney

Thermo Fisher Scientific

Ford Motor

Eli Lilly

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.